These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7804202)

  • 1. Susceptibility of Pneumocystis carinii to a Pichia anomala killer toxin.
    Séguy N; Aliouat EM; Dei-Cas E; Polonelli L; Camus D; Cailliez JC
    J Eukaryot Microbiol; 1994; 41(5):109S. PubMed ID: 7804202
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of a Pichia anomala killer toxin on Pneumocystis carinii infectivity to the SCID mouse.
    Séguy N; Cailliez JC; Polonelli L; Dei-Cas E; Camus D
    Parasitol Res; 1996; 82(2):114-6. PubMed ID: 8825204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis.
    Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
    FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):145-9. PubMed ID: 9792073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of a Pichia anomala killer toxin on the viability of rat-derived Pneumocystis carinii.
    Jackson HC; Séguy N; Killigin EM; Dei-Cas E; Polonelli L; Cailliez JC
    J Eukaryot Microbiol; 1996; 43(5):29S. PubMed ID: 8822833
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro decrease of rat-derived Pneumocystis carinii attachment induced by human natural yeast killer toxin-like antiidiotypic candidacidal antibodies.
    Séguy N; Polonelli L; Conti S; Dei-Cas E; Camus D; Cailliez JC
    J Eukaryot Microbiol; 1996; 43(5):27S. PubMed ID: 8822831
    [No Abstract]   [Full Text] [Related]  

  • 6. The yeast killer phenomenon: a hypothetical way to control Pneumocystis carinii pneumonia.
    Cailliez JC; Séguy N; Aliouat EM; Polonelli L; Camus D; Dei-Cas E
    Med Hypotheses; 1994 Sep; 43(3):167-71. PubMed ID: 7815973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of anti-toxin antibodies by immunization with Pichia killer toxin-like antiidiotypic monoclonal antibodies.
    Snyder C; Seguy N; Lafitte S; Guyard C; Polonelli L; Cailliez JC; Grzych JM
    J Eukaryot Microbiol; 1999; 46(5):138S. PubMed ID: 10519290
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitory effect of human natural yeast killer toxin-like candidacidal antibodies on Pneumocystis carinii.
    Séguy N; Cailliez JC; Delcourt P; Conti S; Camus D; Dei-Cas E; Polonelli L
    Mol Med; 1997 Aug; 3(8):544-52. PubMed ID: 9307982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killer anti-idiotypes in the control of fungal infections.
    Magliani W; Conti S; Arseni S; Frazzi R; Salati A; Polonelli L
    Curr Opin Investig Drugs; 2001 Apr; 2(4):477-9. PubMed ID: 11566002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus protease inhibitors and Pneumocystis carinii.
    Atzori C; Cargnel A
    J Infect Dis; 2002 Jun; 185(11):1692-3; author reply 1693-4. PubMed ID: 12023783
    [No Abstract]   [Full Text] [Related]  

  • 11. Human, monoclonal and recombinant candidacidal, pneumocysticidal and mycobactericidal antibodies.
    Polonelli L
    Indian J Chest Dis Allied Sci; 2000; 42(4):259-63. PubMed ID: 15597672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis cross infection experiments using SCID mice and nude rats as recipient host, showed strong host-species specificity.
    Aliouat EM; Mazars E; Dei-Cas E; Delcourt P; Billaut P; Camus D
    J Eukaryot Microbiol; 1994; 41(5):71S. PubMed ID: 7804269
    [No Abstract]   [Full Text] [Related]  

  • 13. Reflections on internal images.
    Greenspan NS
    Nat Biotechnol; 1997 Feb; 15(2):123-4. PubMed ID: 9035130
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.
    Magliani W; Conti S; de Bernardis F; Gerloni M; Bertolotti D; Mozzoni P; Cassone A; Polonelli L
    Nat Biotechnol; 1997 Feb; 15(2):155-8. PubMed ID: 9035141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Pneumocystis carinii remain infectious in the bloodstream?
    Denis CM; Cailliez JC; Aliouat EM; Delcourt P; LePage G; Hermant N; Lamouret M; Dei-Cas E
    J Eukaryot Microbiol; 1994; 41(5):86S. PubMed ID: 7804281
    [No Abstract]   [Full Text] [Related]  

  • 16. Pneumocystis carinii: the art and science of survival in the hostile environment of the alveolar spaces.
    Martin WJ
    Semin Respir Infect; 1998 Dec; 13(4):348-52. PubMed ID: 9872632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinfection of rats with genetically diverse forms of Pneumocystis carinii demonstrated by P. carinii inosine monophosphate dehydrogenase gene polymorphism.
    Weinberg GA; O'Gara MJ; Cushion MT
    J Eukaryot Microbiol; 1994; 41(5):119S. PubMed ID: 7804212
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Pichia anomala killer toxin on Candida albicans.
    Mathews HL; Conti S; Witek-Janusek L; Polonelli L
    Med Mycol; 1998 Aug; 36(4):199-204. PubMed ID: 9776835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of fungal contamination in rat-derived Pneumocystis carinii extracts and the effect on uptake of para-aminobenzoic acid.
    Chung V; Shah K
    J Eukaryot Microbiol; 1994; 41(5):80S-81S. PubMed ID: 7804277
    [No Abstract]   [Full Text] [Related]  

  • 20. First steps in the purification and characterization of a Pichia anomala killer toxin.
    Guyard C; Séguy N; Lange M; Ricard I; Polonelli L; Cailliez JC
    J Eukaryot Microbiol; 1999; 46(5):144S. PubMed ID: 10519293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.